Thalassaemia constitutes an especially prevalent human monogenic illness caused by a
lack of synthesis of the α-or β-globin chains. The clinical impact of β-thalassaemia is worse …

Background Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) presents
a promising therapeutic option for pediatric transfusion-dependent thalassemia, particularly …

Infections in hematopoietic stem cell transplant (HSCT) remain one of the major causes for
morbidity and mortality, and it is still unclear whether knowledge of microbial colonization is …

We performed a retrospective analysis on 124 patients with transfusion-dependent
thalassemia who were registered in the German pediatric registry for stem cell …

Background Allo-HSCT is a curative therapy for patients with transfusion-dependent
thalassemia (TDT). The high incidence of transplant-related complications is becoming an …

Haploidentical transplantation strategies for patients with transfusion‐dependent
thalassaemia (TD‐TM) remain to be investigated. In this study, 54 paediatric patients with TD …

Background: Thalassemia, the most common heterogeneous single gene disorder causing
sever genetic health problem in the world. In 1932 George and William gave it the name …

Aim To investigate the effects of anti‐human Leucocyte Antigen (HLA) antibody positivity on
early hematopoietic stem cell transplantation (HSCT) results in patients with thalassemia …

In patients with sickle cell disease (SCD) and beta-thalassemia major (TM), allogeneic
hematopoietic stem cell transplantation (HSCT) was considered the only curative treatment …

Background The aim of this study was to assess the impact of serum panel reactive
antibodies (PRA) on the outcomes of allogeneic hematopoietic stem cell transplantation …